Cantor Fitzgerald just bumped price targets on Eli Lilly, AbbVie, Merck, and Pfizer, but higher targets do not mean equal conviction. The firm's split between Overweight and Neutral ratings reveals a sharp divide in…
Oracle's cloud backlog keeps growing and its quarterly results keep beating estimates, yet the stock sits near a 52-week low. Something in that gap is either a serious warning sign or the biggest mispricing…
Wells Fargo just slapped a four-digit price target on Meta, but the stock has gone nowhere in a year despite 28% revenue growth. Here is what has to happen for the math to actually…
Dell's AI customer list is exploding and its backlog dwarfs what Wall Street expects, yet analysts have barely moved their price targets. Here is what the numbers actually suggest about where this stock could…
Fifty-eight analysts cover Amazon and not one rates it a sell, yet the stock still sits well below its 52-week high while free cash flow turns negative and capital spending surges to levels that…
Apple sits on 2.5 billion active devices and a Services engine already running near $120 billion annually, yet one margin warning and a below-consensus analyst target raise a serious question about whether the premium…
Alphabet trades at a lower earnings multiple than Microsoft and Meta while growing faster than both, yet the stock sits nearly 15% below its 52-week peak. One specific catalyst in 2027 could be what…
Among the Magnificent 7, one stock sits just below its 52-week high with a $678 billion backlog, zero analyst sell ratings, and a capex bet so large it could either supercharge returns or pressure…
Arm shares have surged nearly 177% this year, every major AI platform runs its chips, and customer demand for its flagship CPU just blew past management's own projections. So why does one closely watched…
Every analyst covering Alphabet leans bullish, yet the stock sits well below its 52-week high while free cash flow just turned negative and long-term debt doubled. Something has to give, and Wall Street's unanimous…
Tesla is burning through cash, missing earnings estimates, and trading at a valuation that stretches belief, yet one wild card in its portfolio could rewrite the entire story for 2027.
NVIDIA just posted triple-digit revenue growth and Wall Street is calling for another 40% gain, yet the stock keeps dropping after every earnings beat. Here is what three very specific things have to happen…
Everyone knows the AWS story, but three faster-growing businesses quietly running alongside it could change how investors value Amazon entirely.
BNP Paribas just slapped a price target on AMD that towers over Wall Street consensus, but reaching it would demand a sequence of wins that our model says the stock has not yet earned.
Netflix shares have dropped 26% this year even as revenue keeps climbing, and a largely overlooked segment of its business could be the catalyst that catches investors off guard.
Cisco just posted its fifth straight earnings beat while AI infrastructure orders piled up, but the real question is whether the valuation still leaves room to run or whether this rally has already priced…
Costco parking lots are packed, yet the stock sits well below its 52-week high while tariff headwinds and margin pressure cloud the outlook. Whether those forces are temporary noise or a real warning sign…
Wall Street just flooded Marvell with price target hikes after a single Investor Day presentation, and the earnings framework at the center of the bullish case is raising eyebrows even among analysts who support…
Palantir just posted its ninth straight earnings beat and the stock surged, but one metric buried in the quarterly report now controls whether the premium multiple holds or collapses under rising costs and slowing…
Marvell Technology has already delivered 2,100% returns over a decade and 216% gains this year alone, but reaching $1,000 demands something far more ambitious than momentum. Here is what the math actually requires.
